JP Morgan has secured number one position in the latest global mergers and acquisitions (M&A) financial advisers’ league table in the first quarter (Q1) of 2019, according to GlobalData, a leading data analytics company.
The American bank advised on 61 deals worth $331.9bn in Q1 2019, including the quarter’s two biggest deals – Bristol-Myers Squibb’s plan to acquire Celgene for $89.5bn and Saudi Aramco’s acquisition of a 70% stake in SABIC. JP Morgan recorded a marginal increase in deal value during Q1 2019 when compared with Q1 2018, despite dip in volume.
GlobalData compiles the league table using real-time data tracked from all merger and acquisition, private equity/venture capital and asset transaction activity globally. Goldman Sachs stood at second place with a total deal value of $301bn from 71 deals it advised on during the quarter, witnessing a year-on-year deal value growth of 6.61%. Third position was occupied by Citi, which worked on 48 deals in Q1 2019 as against 65 in Q1 2018.
Morgan Stanley and Evercore Partners secured fourth and fifth positions, having worked on 55 deals worth $227.4bn and 44 deals worth $179.1bn, respectively. In terms of growth in year-on-year deal value, Morgan Stanley witnessed a 27.54% decline in Q1 2019 while Evercore Partners recorded a 76.80% increase.
Goldman Sachs and Rothschild & Co led the chart in terms of volume, advising 71 deals each in Q1 2019. JP Morgan secured second position with 61 deals followed by Morgan Stanley with 55.
Ravi Tokala, Financial Deals Analyst at GlobalData, comments: “The $89.5bn deal between Bristol-Myers Squibb and Celgene played an instrumental role in deciding the first half of the league table. Four among the top five advisers were part of this deal. Three of the top five advisers in the league table worked on Saudi Aramco and SABIC deal.”
The overall year-on-year deal value declined by 8.24% to $956.40bn but witnessed a 20.04% increase from Q4 2018.
In Q1 2019, 13,576 deals were recorded globally, marking a 37.03% increase from Q1 2018, and a 3.67% rise from Q4 2018.